Abstract
Introduction and hypothesis
Female pelvic organ prolapse (POP) is a common condition, with a lifetime risk for surgery of 10–20%. Prolapse procedures are known to have a high reoperation rate. It is assumed that etiological factors for POP may also be risk factors for POP recurrence after surgery. There are few reviews available evaluating risk factors for prolapse and recurrence or recently updated meta-analysis on this topic. Our aim was to perform a systematic review and quantitative meta-analysis to determine risk factors for prolapse recurrence after reconstructive surgery.
Methods
Four electronic databases (MEDLINE, PubMed, EMBASE, and Google Scholar) were searched between 1995 and 1 January 2017, with no language restrictions.
Results
Twenty-five studies met inclusion criteria for a total of 5082 patients with an average recurrence rate of 36%. Variables on which a meta-analysis could be performed were body mass index (BMI) (n = 12), age (n = 11), preoperative stage (n = 9), levator avulsion (n = 8), parity (n = 8), constipation/straining (n = 6), number of compartments involved (n = 4), prior hysterectomy (n = 4), familiy history (n = 3), and several other predictors evaluated in only three studies. The following meta- analyses identified significant predictors: levator avulsion [odds ratio (OR) 2.76, P < 0.01], preoperative stage 3–4 (OR 2.11, P < 0.001), family history (OR 1.84, P = 0.006), and hiatal area (OR 1.06/cm2, P = 0.003).
Conclusions
Levator avulsion, prolapse stage, and family history are significant risk factors for prolapse recurrence.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Female pelvic organ prolapse (POP) is a common condition with a multifactorial etiology [1] that varies between patients [2]. It is associated with a significant impairment in overall quality of life (QoL) [3]. The lifetime risk for prolapse surgery has been documented as being 10–20% [4, 5]. Reconstructive surgery is known to have a high reoperation rate (8.5–58%) [4, 6,7,8]. To date, little is known about factors associated with surgical failure; however, it is assumed that factors that play a role in POP etiology and pathogenesis may also be risk factors for recurrence [9,10,11,12,13,14]. It is clearly important to identify risk factors for recurrence to provide preoperative consultation and realistic patient expectations after tailoring their most appropriate treatment methodology: conservative or surgical. This is also importat for clinical research, as novel treatment approaches should first be tested in women likely to fail conventional treatment, limiting certain, more invasive, treatment approaches to those at high risk of recurrence.
It is assumed that POP recurrence may be associated with a combination of predisposing, inciting, and intervening factors, but to date, it has not been possible to weigh the importance of risk factors reported in the literature [9]. Several systematic reviews evaluate risk factors for prolapse and recurrence [7, 10, 15,16,17,18]; however, we found no recent meta-analysis on this issue.
Methods
Study protocol
We followed the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines [19] and searched MEDLINE, PubMed, Google Scholar, and EMBASE to 1 January 2017 to identify relevant articles. Our search items included Pelvic Organ Prolapse OR Female pelvic organ prolapse OR genital prolapse OR Urogenital prolapse OR Cystocele OR Bladder Prolapse AND Recurrence OR Relapse OR Reoperation AND Risk factors OR predictors OR Epidemiology. The reference lists of relevant articles were searched for appropriate studies. No language restrictions were used, and a search for unpublished literature was performed.
Study selection
We selected studies that met the following criteria: risk factors for recurrence of prolapse; (risk-point estimate reported as odds ratio (OR) or data presented such that an OR could be calculated; 95% confidence interval (CI) or data presented such that the CI could be calculated; (internal comparison when calculating risk estimate.
Data extraction
The data extraction was performed using a standardized data extraction form with information on publication year, study design, number of cases, number of controls, total sample size, temporal direction, population type, country, continent, economic development, case–control matching, mean age, number of adjusted variables, risk estimates or data used to calculate risk estimates, and CIs or data used to calculate CIs. Study quality was not assessed. Several authors were contacted for missing data. Adjusted ratios were extracted in preference to nonadjusted ratios; however, where adjusted ratios were not provided, unadjusted ORs and CIs were calculated. Where more than one adjusted ratio was reported, we chose the ratio with the highest number of adjusted variables. Where multiple risk estimates were available in the same study, for example due to the use of different comparator groups, they were included as separate risk estimates.
Statistical analysis
Pooled ORs and 95% CIs were calculated for the effect of body mass index (BMI), age, preoperative prolapse stage, levator avulsion, parity, constipation/ obstructed defecation, number of involved compartments, prior hysterectomy, and family history of prolapse on the risk of prolapse recurrence using a random effects model [20]. We tested heterogeneity with Cochran’s Q statistic, with P < 0.10 indicating heterogeneity, and quantified the degree of heterogeneity using the I2 statistic, which represents the percentage of total heterogeneity variability across studies. I2 values of 25, 50, and 75% corresponded to low, moderate, and high degrees of heterogeneity, respectively [21]. We quantified publication bias using Egger’s regression model [22], with the effect of bias assessed using the fail-safe number method. The fail-safe number was the number of missed studies necessary to nullify our observed results to statistical nonsignificance at the p < 0.05 level. Publication bias is generally regarded as a concern if the fail-safe number is N 5n + 10, with n being the number of studies in the meta-analysis [23]. All analyses were performed with Comprehensive Meta-analysis, version 3.0 (Biostat, Englewood, NJ , USA).
Results
From 3548 citations screened by our search, we identified 25 studies that met inclusion criteria (Fig. 1). Table 1 shows selected characteristics of these studies, with 5082 patients and an average recurrence rate of 36%. Seven studies were conducted in Europe, 12 in the USA, one in Asia, and five in Australia. Cited and retrieved categories were publication year, study type, continent, number of patients included, recurrent percentage, follow-up period, definition of prolapse recurrence, and inclusion criteria for each study, as different studies used different definitions for recurrence: e.g., need for reoperation [even for stress urinary incontinence (SUI) after prolapse surgery], stage ≥ 2 prolapse, Bp > 0, etc (Table 1). Evaluated risk factors—either provided or calculated—were BMI (12 studies), age (11 studies), preoperative stage (9 studies), levator avulsion and parity (8 studies each), constipation/ obstructed defecation (6 studies), number of involved compartments and prior hysterectomy (4 studies each), family history of prolapse (3 studies), and hiatal area, levator contractility, genital hiatus length, presence of urge urinary incontinence (UUI), and surgeon experience (2 studies each). Several parameters were evaluated once: assisted vaginal delivery, sling operation, weight, past macrosomic baby, urinary incontinence (UI), fecal incontinence (FI), need to splint, stress urinary incontinence (SUI), and urinary retention. Factors evaluated as being associated with prolapse are limited by currently used assessment techniques. Several potential mechanical factors could not be assessed because such measurements were not done prior to surgery in the literature. For example, no study investigated the mechanical properties of apical ligaments or the force generated by a levator ani muscle contraction.
For each parameter investigated in at least 2 studies, a meta-analysis was attempted. However, due to differences in definitions, we could not include all identified papers. For instance, a number of studies compared BMI > 30 to normal, some compared BMI > 25 to normal, and in some, the definition was not clear. Similar issues arose with age as a predictor of recurrence. In such situations, we used the most common definition. Meta-analysis was performed for levator muscle avulsion, (9 studies, Fig. 2), family history of prolapse (3 studies, Fig. 3), preoperative prolapse staging (8 studies, Fig. 4), prior hysterectomy (4 studies, Fig. 5), hiatal area on Valsalva (2 studies, Fig. 6), obstructed defecation (6 studies, Fig. 7), and obesity and overweight (6 studies, Fig. 8).
Significant OR and CI were found for levator avulsion (2.76, 95% CI 2.17–3.51, P < 0.01), preoperative staging 3–4 (2.11, 95% CI 1.65–2.70, P < 0.001), family history (1.84, 95% CI 1.19–2.86, P = 0.006), and hiatal area (1.06/cm2, 95% CI 1.02–1.10, P = 0.003). There was no evidence of publication bias based of Egger’s regression analysis for any of the risk factors assessed: avulsion (P = 0.26; Fig. 9), family history (P = 0.16), preoperative prolapse staging (P = 0.18), prior hysterectomy (P = 0.20), hiatal area (insufficient data), obstructed defecation (P = 0.73), and obesity and overweight (P = 0.06).
Discussion
This systematic review and meta-analysis evaluated 25 studies in which > 5000 women with POP were assessed for recurrence following primary surgical treatment, with a follow-up period of 0.11–10 years. Most studies defined recurrence as Pelvic Organ Quantification (POP-Q) system stage > 2 for any compartment; however, there were also other definitions, such as a second operation or POP-Q stage 2 for the operated compartment (Table 1). Our review provides an overview of investigated risk factors and their contribution (OR, CI) to prolapse recurrence; significance found for the following risk factors: levator avulsion, preoperative staging 3–4, familial history, and levator hiatal area measured on Valsalva. Although these risk factors have been identified in several studies, our analysis did not always reach statistical significance. The power of any meta-analysis lies in its ability to overcome power issues commonly inherent in published studies, and in this regard, we believe we reached valid and plausible conclusions.
Studies show that pelvic reconstructive surgery has a high reoperation rate [4, 6,7,8, 11]. Prolapse recurrence is becoming increasingly topical, not least due to the mounting availability of surgical options, such as traditional approaches (vaginal or abdominal) alongside more recently developed laparoscopic and robotic procedures, with or without the use of synthetic or biological implants. Little is known about factors associated with surgical failure, few published systematic reviews evaluate risk factors for prolapse and recurrence, and we found no recent meta-analysis on this topic. Hence, we believe this work substantially adds to the information currently available in the literature regarding risk factors for prolapse recurrence.
Strengths and limitations
The strengths of this study include its thorough and systematic review, the large population size (25 studies published over 17 years from four continents, and > 5000 patients. On the other hand, it is well known that systematic reviews of prognostic studies are complicated by several issues [44]. In our meta-analysis, the difference in recurrent prolapse definition and inclusion criteria for each study, as well as the huge diversity in risk-factor definitions, narrowed our ability to compare and use all available information in our statistical analysis. As noted by others [45], uniformly accepted criteria for prolapse recurrence are lacking. A widely accepted consensus regarding the definition of recurrent prolapse and risk factors will benefit future iterations of our work. In addition, data was largely obtained from retrospective studies, and surgical treatment type varied widely between simple and complicated procedures, between vaginal, abdominal, and laparoscopic approaches, and few studies included mesh surgery. However, population heterogeneity and included procedures may be seen as an advantage, representing universally applicable results, and the overall recurrence rate of 36% is plausible in many different settings. Also, that most studies were done in developed countries with similar population profiles is clearly an additional limitation, especially considering emerging data on interethnic variations in pelvic organ support in general and POP in particular [46, 47]. Combining adjusted and unadjusted OR is another limitation that overemphasizes results gleaned from the unadjusted ratios alone, which are typically larger than adjusted values. Risk factors identified by us are unlikely to be independent: Hiatal area is clearly associated with avulsion [48,49,50] and prolapse stage [51]. A congenital component is likely, as indicated by family history, but any genetic predisposition may, in turn, affect levator hiatus distensibility and/or the likelihood of major levator trauma during childbirth. Finally, it is increasingly apparent that both etiology and pathophysiology may vary considerably from one compartment to the other. This is certainly the case for levator trauma [51]. The role of obesity is another example, as it may affect the posterior compartment much more than the anterior or central compartments [52]. Hence, future work in this field should consider prolapse recurrence separately for different compartments.
In conclusion, our meta-analysis demonstrates that levator muscle avulsion, preoperative prolapse stage, family history of prolapse, and levator hiatal area are significant risk factor for prolapse recurrence. To facilitate future work in this field, definitions for recurrent prolapse and risk factors need to be standardized. For the time being, risk factors identified in this meta-analysis may serve to help physicians inform patients, select surgical treatment, and design and plan surgical intervention trials.
References
Dietz H. The aetiology of prolapse. Int Urogynecol J. 2008;19(10):1323.
Schaffer JI, Wai CY, Boreham MK. Etiology of pelvic organ prolapse. Clin Obstet Gynecol. 2005;48(3):639–47.
Fritel X, Varnoux N, Zins M, Breart G, Ringa V. Symptomatic pelvic organ prolapse at midlife, quality of life, and risk factors. Obstet Gynecol. 2009;113(3):609.
Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89(4):501–6.
Smith FJ, Holman CAJ, Moorin RE, Tsokos N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol. 2010;116(5):1096–100.
Benson JT, Lucente V, McClellan E. Vaginal versus abdominal reconstructive surgery for the treatment of pelvic support defects: a prospective randomized study with long-term outcome evaluation. Am J Obstet Gynecol. 1996;175(6):1418–22.
Diwadkar GB, Barber MD, Feiner B, Maher C, Jelovsek JE. Complication and reoperation rates after apical vaginal prolapse surgical repair: a systematic review. Obstetrics & Gynecology. 2009;113(2, Part 1):367–73.
Denman MA, Gregory WT, Boyles SH, Smith V, Edwards SR, Clark AL. Reoperation 10 years after surgically managed pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol. 2008;198(5):555.e551–555. e555
Salvatore S, Siesto G, Serati M. Risk factors for recurrence of genital prolapse. Curr Opin Obstet Gynecol. 2010;22(5):420–4.
Vergeldt TF, Weemhoff M, IntHout J, Kluivers KB. Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J. 2015;26(11):1559.
Whiteside JL, Weber AM, Meyn LA, Walters MD. Risk factors for prolapse recurrence after vaginal repair. Am J Obstet Gynecol. 2004;191(5):1533–8.
Salvatore S, Athanasiou S, Digesu GA, Soligo M, Sotiropoulou M, Serati M, et al. Identification of risk factors for genital prolapse recurrence. Neurourol Urodyn. 2009;28(4):301–4.
Diez-Itza I, Aizpitarte I, Becerro A. Risk factors for the recurrence of pelvic organ prolapse after vaginal surgery: a review at 5 years after surgery. Int Urogynecol J. 2007;18(11):1317.
Jeon MJ, Chung SM, Jung HJ, Kim SK, Bai SW. Risk factors for the recurrence of pelvic organ prolapse. Gynecol Obstet Investig. 2008;66(4):268–73.
Maher C, Baessler K, Glazener C, Adams E, Hagen S. Surgical management of pelvic organ prolapse in women: a short version Cochrane review. Neurourol Urodyn. 2008;27(1):3–12.
Maher CM, Feiner B, Baessler K, Glazener CM. Surgical management of pelvic organ prolapse in women: the updated summary version Cochrane review. Int Urogynecol J. 2011;22(11):1445–57.
Sze H, Karram MM. Transvaginal repair of vault prolapse: a review. Obstet Gynecol. 1997;89(3):466–75.
Barski D, Otto T, Gerullis H. Systematic review and classification of complications after anterior, posterior, apical, and total vaginal mesh implantation for prolapse repair. Surg Technol Int. 2014;24:217–24.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.
Higgins J, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses [journal article as teaching resource, deposited by John Flynn]. Br Med J. 2003;327:557–60.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
Orwin RG. A fail-safe N for effect size in meta-analysis. J Educ Stat. 1983;8(2):157–9.
Kenton K, Sadowski D, Shott S, Brubaker L. A comparison of women with primary and recurrent pelvic prolapse. Am J Obstet Gynecol. 1999;180(6):1415–8.
Goldberg RP, Koduri S, Lobel RW, Culligan PJ, Tomezsko JE, Winkler HA, et al. Protective effect of suburethral slings on postoperative cystocele recurrence after reconstructive pelvic operation. Am J Obstet Gynecol. 2001;185(6):1307–13.
Clark AL, Gregory T, Smith VJ, Edwards R. Epidemiologic evaluation of reoperation for surgically treated pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol. 2003;189(5):1261–7.
Tegerstedt G, Hammarström M. Operation for pelvic organ prolapse: a follow-up study. Acta Obstet Gynecol Scand. 2004;83(8):758–63.
Vakili B, Zheng YT, Loesch H, Echols KT, Franco N, Chesson RR. Levator contraction strength and genital hiatus as risk factors for recurrent pelvic organ prolapse. Am J Obstet Gynecol. 2005;192(5):1592–8.
Fialkow MF, Newton KM, Weiss NS. Incidence of recurrent pelvic organ prolapse 10 years following primary surgical management: a retrospective cohort study. Int Urogynecol J. 2008;19(11):1483–7.
Dietz H, Chantarasorn V, Shek K. Levator avulsion is a risk factor for cystocele recurrence. Ultrasound Obstet Gynecol. 2010;36(1):76–80.
Model AN, Shek KL, Dietz HP. Levator defects are associated with prolapse after pelvic floor surgery. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2010;153(2):220–3.
Morgan DM, Larson K, Lewicky-Gaupp C, Fenner DE, DeLancey JO. Vaginal support as determined by levator ani defect status 6 weeks after primary surgery for pelvic organ prolapse. Int J Gynecol Obstet. 2011;114(2):141–4.
Weemhoff M, Vergeldt TF, Notten K, Serroyen J, Kampschoer PH, Roumen FJ. Avulsion of puborectalis muscle and other risk factors for cystocele recurrence: a 2-year follow-up study. Int Urogynecol J. 2012;23(1):65–71.
Wong V, Shek K, Rane A, Goh J, Krause H, Dietz H. Is levator avulsion a predictor of cystocele recurrence following anterior vaginal mesh placement? Ultrasound Obstet Gynecol. 2013;42(2):230–4.
Kawasaki A, Corey EG, Laskey RA, Weidner AC, Siddiqui NY, Wu JM. Obesity as a risk for the recurrence of anterior vaginal wall prolapse after anterior colporrhaphy. J Reprod Med. 2012;58(5–6):195–9.
Edenfield AL, Amundsen CL, Weidner AC, Wu JM, George A, Siddiqui NY. Vaginal prolapse recurrence after uterosacral ligament suspension in normal-weight compared with overweight and obese women. Obstet Gynecol. 2013;121(3):554–9.
Crosby E, Dewald S, Fenner D, Delancey J, Morgan D. The effect of major levator ani defects on postoperative outcomes after primary surgery for pelvic organ prolapse. In: International urogynecology journal. London: Springer; 2014. p. S44–S45.
Rodrigo N, Wong V, Shek KL, Martin A, Dietz HP. The use of 3-dimensional ultrasound of the pelvic floor to predict recurrence risk after pelvic reconstructive surgery. Aust N Z J Obstet Gynaecol. 2014;54(3):206–11.
Vergeldt T, Notten K, Weemhoff M, Kuijk S, Mulder F, Beets-Tan R, et al. Levator hiatal area as a risk factor for cystocele recurrence after surgery: a prospective study. BJOG Int J Obstet Gynaecol. 2015;122(8):1130–7.
Vergeldt TF, van Kuijk SM, Notten KJ, Kluivers KB, Weemhoff M. Anatomical cystocele recurrence: development and internal validation of a prediction model. Obstet Gynecol. 2016;127(2):341–7.
Abdul Jalil S, Guzmán Rojas R, Dietz HP. Does it matter whether levator avulsion is diagnosed pre-or postoperatively? Ultrasound Obstet Gynecol. 2016;48(4):516–9.
Rappa C, Saccone G. Recurrence of vaginal prolapse after total vaginal hysterectomy with concurrent vaginal uterosacral ligament suspension: comparison between normal-weight and overweight women. Am J Obstet Gynecol. 2016;215(5):601.e1–-e4.
Turner L, Lavelle E, Lowder JL, Shepherd JP. The impact of obesity on intraoperative complications and prolapse recurrence after minimally invasive sacrocolpopexy. Female Pelvic Med Reconstr Surg. 2016;22(5):317–23.
Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ Br Med J. 2001;323(7306):224.
Salvatore S, Siesto G, Rizk DE. Definition of recurrence of pelvic organ prolapse: is it really important? Berlin: Springer; 2011.
Abdool Z, Dietz H, Lindeque B. A comparison of functional pelvic floor anatomy in white and black south african women with symptomatic pelvic organ prolapse. Neurourol Urodyn. 2014;33:910–1.
Cheung RY, Chan SS, Yiu A, Lee L. Prevalence of pelvic organ prolapse in different compartments in symptomatic Chinese women. ICS conference abstract number 199. Parity 2014;69:11.10.
Dietz HP, Franco AV, Shek KL, Kirby A. Avulsion injury and levator hiatal ballooning: two independent risk factors for prolapse? An observational study. Acta Obstet Gynecol Scand. 2012;91(2):211–4.
Dietz H, Bhalla R, Chantarasorn V, Shek K. Avulsion of the puborectalis muscle is associated with asymmetry of the levator hiatus. Ultrasound Obstet Gynecol. 2011;37(6):723–6.
Abdool Z, Shek KL, Dietz HP. The effect of levator avulsion on hiatal dimension and function. Am J Obstet Gynecol. 2009;201(1):89.e81-89. e85
Dietz H, Simpson J. Levator trauma is associated with pelvic organ prolapse. BJOG Int J Obstet Gynaecol. 2008;115(8):979–84.
Young N, Atan I, Dietz H. Obesity: how much does it matter for female pelvic organ prolapse? BJOG Int J Obstet Gynaecol. 2015;122:391.
Funding
This study was unfunded.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
H.P. Dietz has received unrestricted educational grants from GE Medical. T. Friedman and G.D. Eslick have no conflict of interest to declare.
Rights and permissions
About this article
Cite this article
Friedman, T., Eslick, G.D. & Dietz, H.P. Risk factors for prolapse recurrence: systematic review and meta-analysis. Int Urogynecol J 29, 13–21 (2018). https://doi.org/10.1007/s00192-017-3475-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-017-3475-4